Skye Bioscience, Inc. Fair Value Adjustment of Warrants
Skye Bioscience, Inc. (SKYE) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2025-03-20
- Skye Bioscience, Inc. fair value adjustment of warrants for the quarter ending 2023-12-31 was $0.00.
- Skye Bioscience, Inc. fair value adjustment of warrants for the quarter ending 2023-09-30 was $0.00.
- Skye Bioscience, Inc. fair value adjustment of warrants for the quarter ending 2023-06-30 was $0.00.
- Skye Bioscience, Inc. fair value adjustment of warrants for the quarter ending 2023-03-31 was -$3.00.
- Skye Bioscience, Inc. fair value adjustment of warrants for fiscal 2024 was $0.00.
- Skye Bioscience, Inc. fair value adjustment of warrants for fiscal 2023 was -$3.00.
- Skye Bioscience, Inc. fair value adjustment of warrants for fiscal 2022 was -$59.73K, a 382.21% decline from fiscal 2021.
- Skye Bioscience, Inc. fair value adjustment of warrants for fiscal 2021 was $21.16K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 3 month as first filed | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 6 month as first filed | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 9 month as first filed | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-20 | |||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $0.00 derived: sum of 2 quarters · filed 2025-03-20 | $0.00 derived: sum of 3 quarters · filed 2025-03-20 | -$3.00 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | -$3.00 10-Q · filed 2023-11-14 | -$326.00 derived: sum of 4 quarters · filed 2024-03-22 | ||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$3.00 10-Q · filed 2023-08-07 | -$326.00 derived: sum of 3 quarters · filed 2024-03-22 | -$6.55K derived: sum of 4 quarters · filed 2024-03-22 | ||||
| 2023-03-31 | -$3.00 10-Q · filed 2023-05-12 | -$326.00 derived: sum of 2 quarters · filed 2024-03-22 | -$6.55K derived: sum of 3 quarters · filed 2024-03-22 | -$16.08K derived: sum of 4 quarters · filed 2024-03-22 | ||||
| 2022-12-31 | -$323.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$6.55K derived: sum of 2 quarters · filed 2024-03-22 | -$16.07K derived: sum of 3 quarters · filed 2024-03-22 | -$59.73K 10-K · filed 2024-03-22 | ||||
| 2022-09-30 | -$6.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$15.75K derived: sum of 2 quarters · filed 2023-11-14 | -$59.41K 10-Q · filed 2023-11-14 | -$207.59K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$9.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$53.18K 10-Q · filed 2023-08-07 | -$201.36K derived: sum of 3 quarters · filed 2023-08-07 | -$391.01K derived: sum of 4 quarters · filed 2023-08-07 | ||||
| 2022-03-31 | -$43.66K 10-Q · filed 2023-05-12 | -$191.84K derived: sum of 2 quarters · filed 2023-05-12 | -$381.49K derived: sum of 3 quarters · filed 2023-05-12 | -$260.84K derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | -$148.18K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$337.83K derived: sum of 2 quarters · filed 2023-03-31 | -$217.19K derived: sum of 3 quarters · filed 2023-03-31 | $21.16K 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | -$189.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$69.00K derived: sum of 2 quarters · filed 2022-11-14 | $169.35K 10-Q · filed 2022-11-14 | $166.77K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $120.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $359.00K 10-Q · filed 2022-08-15 | $356.42K derived: sum of 3 quarters · filed 2022-08-15 | -$67.72K derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $238.35K 10-Q · filed 2022-05-06 | $235.77K derived: sum of 2 quarters · filed 2022-05-06 | -$188.37K derived: sum of 3 quarters · filed 2022-05-06 | -$162.02K derived: sum of 4 quarters · filed 2022-05-06 | ||||
| 2020-12-31 | -$2.58K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$426.72K derived: sum of 2 quarters · filed 2022-03-28 | -$400.37K derived: sum of 3 quarters · filed 2022-03-28 | -$436.27K 10-K · filed 2022-03-28 | ||||
| 2020-09-30 | -$424.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$397.79K derived: sum of 2 quarters · filed 2021-11-10 | -$433.69K 10-Q · filed 2021-11-10 | -$8.14M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $26.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$9.55K 10-Q · filed 2021-08-06 | -$7.72M derived: sum of 3 quarters · filed 2021-08-06 | -$4.59M derived: sum of 4 quarters · filed 2021-08-06 | ||||
| 2020-03-31 | -$35.90K 10-Q · filed 2021-05-07 | -$7.75M derived: sum of 2 quarters · filed 2021-05-07 | -$4.62M derived: sum of 3 quarters · filed 2021-05-07 | -$22.59M derived: sum of 4 quarters · filed 2021-05-07 | ||||
| 2019-12-31 | -$7.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | -$4.58M derived: sum of 2 quarters · filed 2021-03-02 | -$22.56M derived: sum of 3 quarters · filed 2021-03-02 | -$9.73M 10-K · filed 2021-03-02 | ||||
| 2019-09-30 | $3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$14.85M derived: sum of 2 quarters · filed 2020-11-06 | -$2.02M 10-Q · filed 2020-11-06 | $2.83M derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | -$17.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$5.15M 10-Q · filed 2020-08-13 | -$301.43K derived: sum of 3 quarters · filed 2020-08-13 | $749.30K derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $12.82M 10-Q · filed 2020-05-08 | $17.67M derived: sum of 2 quarters · filed 2020-05-08 | $18.72M derived: sum of 3 quarters · filed 2020-05-08 | $20.30M derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $4.85M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $5.90M derived: sum of 2 quarters · filed 2020-03-23 | $7.48M derived: sum of 3 quarters · filed 2020-03-23 | $6.50M 10-K · filed 2020-03-23 | ||||
| 2018-09-30 | $1.05M 10-Q · filed 2018-11-14 | $2.63M derived: sum of 2 quarters · filed 2018-11-14 | $1.65M 10-Q · filed 2019-11-14 | $1.47M 10-Q · filed 2018-11-14 | $1.21M derived: sum of 4 quarters · filed 2019-05-10 | |||
| 2018-06-30 | $1.58M 10-Q · filed 2018-08-10 | $602.75K 10-Q · filed 2019-08-09 | $417.75K 10-Q · filed 2018-08-10 | $156.05K derived: sum of 3 quarters · filed 2019-05-10 | -$125.45K derived: sum of 4 quarters · filed 2019-05-10 | |||
| 2018-03-31 | -$977.49K 10-Q · filed 2019-05-10 | -$1.16M 10-Q · filed 2018-05-15 | -$1.42M derived: sum of 2 quarters · filed 2019-05-10 | -$1.71M derived: sum of 3 quarters · filed 2019-05-10 | -$1.73M derived: sum of 4 quarters · filed 2019-05-10 | |||
| 2017-12-31 | -$446.70K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$728.20K derived: sum of 2 quarters · filed 2019-03-14 | -$754.64K derived: sum of 3 quarters · filed 2019-03-14 | -$767.20K 10-K · filed 2019-03-14 | -$560.99K 10-K · filed 2018-03-19 | |||
| 2017-09-30 | -$281.50K 10-Q · filed 2018-11-14 | -$307.93K derived: sum of 2 quarters · filed 2018-11-14 | -$320.50K 10-Q · filed 2018-11-14 | -$78.18K derived: sum of 4 quarters · filed 2018-11-14 | ||||
| 2017-06-30 | -$26.44K 10-Q · filed 2018-08-10 | -$39.00K 10-Q · filed 2018-08-10 | $203.32K derived: sum of 3 quarters · filed 2018-08-10 | $230.99K derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2017-03-31 | -$12.56K 10-Q · filed 2018-05-15 | $229.76K derived: sum of 2 quarters · filed 2018-05-15 | $257.42K derived: sum of 3 quarters · filed 2018-05-15 | -$1.77M derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | $242.32K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | $269.98K derived: sum of 2 quarters · filed 2018-03-19 | -$1.75M derived: sum of 3 quarters · filed 2018-03-19 | -$1.34M 10-K · filed 2018-03-19 | ||||
| 2016-09-30 | $27.66K 10-Q · filed 2017-11-14 | -$2.00M derived: sum of 2 quarters · filed 2017-11-14 | -$1.58M 10-Q · filed 2017-11-14 | |||||
| 2016-06-30 | -$2.02M 10-Q · filed 2017-08-11 | -$1.61M 10-Q · filed 2017-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |